Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIROUETTE trial
ISRCTN91621241Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of pirfenidone in heart failure (HF) and heart failure with preserved ejection fraction (HFpEF), sponsored by Manchester University NHS Foundation Trust. Started Jan 2017; status: completed.
02
Drugs
pirfenidone
03
Conditions
heart failure (HF)heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on ISRCTN91621241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91621241.